When an injectable medication is introduced into tissue, the body’s ability to absorb it depends on the medication dispersing from the injection site and entering the lymphatic and circulatory systems. Water-soluble compounds can dissolve in tissue fluid and are readily absorbed. Oily compounds that do not mix with water tend to remain localized at the injection site, forming droplets that the body has difficulty dispersing. Very viscous substances also resist the mechanical dispersion that injection itself provides — they tend to stay together rather than spreading out.
The chaulmoogra oil’s active fatty acids — chaulmoogric acid and hydnocarpic acid, with their distinctive cyclopentenyl ring structures — are inherently oily compounds. They are, in chemical terms, hydrophobic: they repel water and prefer to associate with other oily or lipophilic substances. Making them water-soluble was not possible through simple modification, because water-solubility and lipophilicity are fundamentally opposing properties. The goal was not to make the fatty acids truly water-soluble but to make them more amenable to injection — less viscous, more able to form a stable injectable preparation, and more capable of being absorbed from the injection site.
The ethyl ester conversion achieved this by modifying the chemical form of the fatty acids. The carboxylic acid group at one end of a fatty acid carries an OH group that can participate in hydrogen bonding with water molecules — and in the free acid form, this group is acidic, contributing to some of the skin and tissue irritation caused by injecting the raw oil. When the fatty acid is converted to its ethyl ester, the OH group is replaced by an -OEt group. This eliminates the acidic character, reduces the tendency to react with tissue proteins, and changes the overall physical behavior of the compound in ways that make it more suitable for injection.
